How to Order Paxlovid (Nirmatrelvir/Ritonavir)
To properly order Paxlovid, prescribe nirmatrelvir 300 mg (two 150 mg tablets) with ritonavir 100 mg (one 100 mg tablet) to be taken together orally twice daily for 5 days, initiated within 5 days of COVID-19 symptom onset. 1, 2
Patient Selection and Timing
Identify eligible patients:
- High-risk adults with mild-to-moderate COVID-19
- Treatment must begin within 5 days of symptom onset
- Prioritize patients at high risk for hospitalization or death 1
Assess renal function:
- Normal to mild impairment (eGFR ≥60 mL/min): Standard dose
- Moderate impairment (eGFR 30-59 mL/min): Reduced dose of 150 mg nirmatrelvir with 100 mg ritonavir twice daily
- Severe impairment (eGFR <30 mL/min): Day 1: 300 mg nirmatrelvir with 100 mg ritonavir once; Days 2-5: 150 mg nirmatrelvir with 100 mg ritonavir once daily 1, 2, 3
Assess hepatic function:
- Not recommended in patients with severe hepatic impairment (Child-Pugh Class C) 2
Critical Step: Drug Interaction Screening
This is the most important safety consideration when ordering Paxlovid:
- Review ALL medications the patient is currently taking
- Check for contraindicated medications that interact with ritonavir (strong CYP3A inhibitor)
- Use the Liverpool COVID-19 Drug Interaction Tool to identify and manage potential interactions 1
- Common problematic medications include:
Prescription Details
Standard dosing:
- Nirmatrelvir 300 mg (two 150 mg tablets) with ritonavir 100 mg (one 100 mg tablet)
- Take all three tablets together twice daily for 5 days
- Can be taken with or without food 2
Administration instructions:
Patient Education
When ordering Paxlovid, ensure patients understand:
- The importance of starting treatment within 5 days of symptom onset
- The need to complete the full 5-day course
- Common side effects: dysgeusia (altered taste) and diarrhea 5
- The critical importance of disclosing all medications they are taking
- To report any serious side effects immediately
Common Pitfalls to Avoid
- Failure to screen for drug interactions - this is the most common and potentially dangerous error
- Not adjusting dosage for renal impairment
- Prescribing beyond 5 days from symptom onset
- Not completing the full treatment course
- Not specifying the numeric dose of each active ingredient 2
Special Considerations
- Pregnancy: Paxlovid represents an option for pregnant people with COVID-19 to reduce disease progression risk 1
- Hemodialysis patients: Administer dose after hemodialysis 2
- Drug interactions: May require dose adjustments, temporary discontinuation, or additional monitoring of concomitant medications 1, 2
Remember that Paxlovid has demonstrated an 89% relative risk reduction in hospitalization and death when given within 3 days of symptom onset in high-risk, unvaccinated adults 5, making proper and timely prescribing crucial for optimal patient outcomes.